Literature DB >> 1633742

Clinical and ERG data in a family with autosomal dominant RP and Pro-347-Arg mutation in the rhodopsin gene.

G Niemeyer1, P Trüb, A Schinzel, A Gal.   

Abstract

In a family with autosomal dominant retinitis pigmentosa, documented over six generations, a previously undescribed point mutation in the rhodopsin gene could be identified. The mutation found in the six affected members examined but in none of the controls, including healthy members of the family, was a point mutation in codon 347 predicting a substitution of the amino acid arginine for proline, designated Pro-347-Arg. Six affected members from two generations were examined clinically and with ganzfeld rod and cone electroretinography. The cone and, more dramatically, the rod electroretinograms were reduced to residual b-wave amplitudes or were non-detectable as early as ages 18 to 22 years. The Pro-347-Arg mutation resulted in a subjectively and clinically homogeneous phenotype: early onset of night blindness before age 11, relatively preserved usable visual fields until about age 30, blindness at ages 40 to 60, and change from an initial apparently sine pigmento to a hyperpigmented and atrophic fundus picture between 30 and 50 years of age.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1633742     DOI: 10.1007/bf00160945

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  16 in total

1.  [ERG in Behçet's disease (author's transl)].

Authors:  M Hatt; G Niemeyer
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1976-02-04

2.  [Not Available].

Authors:  E AMMANN
Journal:  Ophthalmologica       Date:  1946-08       Impact factor: 3.250

3.  Electroretinography: Some basic principles.

Authors:  P Gouras
Journal:  Invest Ophthalmol       Date:  1970-08

4.  Unusual electroretinograms.

Authors:  G Niemeyer
Journal:  Dev Ophthalmol       Date:  1984

5.  Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa.

Authors:  T P Dryja; T L McGee; L B Hahn; G S Cowley; J E Olsson; E Reichel; M A Sandberg; E L Berson
Journal:  N Engl J Med       Date:  1990-11-08       Impact factor: 91.245

6.  A point mutation of the rhodopsin gene in one form of retinitis pigmentosa.

Authors:  T P Dryja; T L McGee; E Reichel; L B Hahn; G S Cowley; D W Yandell; M A Sandberg; E L Berson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

7.  Ocular findings in patients with autosomal dominant retinitis pigmentosa and rhodopsin, proline-347-leucine.

Authors:  E L Berson; B Rosner; M A Sandberg; C Weigel-DiFranco; T P Dryja
Journal:  Am J Ophthalmol       Date:  1991-05-15       Impact factor: 5.258

8.  Two forms of autosomal dominant primary retinitis pigmentosa.

Authors:  R W Massof; D Finkelstein
Journal:  Doc Ophthalmol       Date:  1981-11       Impact factor: 2.379

9.  A 3-bp deletion in the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa.

Authors:  C F Inglehearn; R Bashir; D H Lester; M Jay; A C Bird; S S Bhattacharya
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

10.  Refractive errors of retinitis pigmentosa patients.

Authors:  P A Sieving; G A Fishman
Journal:  Br J Ophthalmol       Date:  1978-03       Impact factor: 4.638

View more
  3 in total

1.  Identification of a novel p.R1443W mutation in RP1 gene associated with retinitis pigmentosa sine pigmento.

Authors:  Li Ma; Xun-Lun Sheng; Hui-Ping Li; Fang-Xia Zhang; Ya-Ni Liu; Wei-Ning Rong; Jian-Ling Zhang
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

2.  Ocular findings in a family with autosomal dominant retinitis pigmentosa and a frameshift mutation altering the carboxyl terminal sequence of rhodopsin.

Authors:  E Apfelstedt-Sylla; M Kunisch; M Horn; K Rüther; H Gerding; A Gal; E Zrenner
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

3.  Mutation analysis of codons 345 and 347 of rhodopsin gene in Indian retinitis pigmentosa patients.

Authors:  M Dikshit; R Agarwal
Journal:  J Genet       Date:  2001-08       Impact factor: 1.508

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.